Both the insulin A receptor and the IGF-2 receptor mediate their effects through common oncogenic signaling pathways such as Ras/MAPK and β-catenin, which explains at least in part their involvement in carcinogenesis and the possibility that a chronic increase in circulating insulin levels leads to an increased risk of cancer in insulin-resistant subjects [35]. Here, INS is linked to cancer.